Feline Hyperthyroidism Treatment Options and Welfare Outcomes

Hyperthyroidism affects over 10% of cats over 10 years and is highly treatable, with radioiodine therapy offering the best long-term welfare outcome for most affected cats.

Key Facts

Hyperthyroidism is the most common endocrine disorder in cats over 10 years
Signs include weight loss, increased appetite, hyperactivity, vomiting, and heart disease
Radioiodine treatment is curative in over 95% of cases without surgery or ongoing medication
Medical management with methimazole/carbimazole requires twice-daily tablets or topical application
Concurrent renal disease can be unmasked after treatment, requiring careful monitoring

Welfare Considerations

Untreated hyperthyroid cats experience progressive weight loss, cardiac disease, hypertension, and anxiety despite their apparently vigorous appetite. The condition causes chronic welfare compromise that significantly shortens life. Treatment dramatically improves quality of life, with most cats showing rapid weight gain, reduced anxiety, and improved coat condition. Radioiodine is the gold standard as it offers a permanent cure without the daily stress of medication administration, benefiting both cat and owner welfare.

What You Can Do

Have cats over 10 years screened annually for thyroid disease
Discuss radioiodine referral with your vet as a permanent curative option
Monitor renal function carefully after starting hyperthyroid treatment
Provide comfortable, calm environments during the treatment period
Join hyperthyroid cat owner communities for shared management experience